Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PAYS | Common Stock | Options Exercise | $233K | +60K | +102.23% | $3.88 | 119K | Feb 28, 2023 | Direct | F1 |
transaction | PAYS | Common Stock | Sale | -$101K | -27.2K | -22.94% | $3.70 | 91.5K | Mar 1, 2023 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | On January 6, 2021, the reporting person received a grant of 300,000 shares of common stock vesting annually in equal amounts over a five-year period commencing on February 28, 2022. As of the date of this filing, 120,000 shares of common stock have vested and been issued. |
F2 | The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | These shares of common stock were sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |